Lapatinib Terminated Phase 2 Trials for Male Breast Cancer / Recurrent Breast Cancer / Stage IIIC Breast Cancer / Stage IIIB Breast Cancer / Stage IIIA Breast Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01868503Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer